Skip to main content

Advertisement

Log in

Fecal polymerase chain reaction for Mycobacterium tuberculosis IS6110 to distinguish Crohn’s disease from intestinal tuberculosis

  • Original Article
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

We have previously shown that amplification of Mycobacterium tuberculosis specific DNA (TB PCR) from feces reliably diagnosed intestinal tuberculosis. This study was undertaken to determine how well this test would distinguish intestinal tuberculosis from Crohn’s disease in a country endemic for tuberculosis.

Methods

Consecutive patients with diagnoses of Crohn’s disease and intestinal tuberculosis were enrolled, and the diagnoses confirmed by follow up. DNA was extracted from fecal samples and subjected to polymerase chain reaction TB PCR for IS6110 sequence which is specific for M. tuberculosis.

Results

Twenty one of 24 patients with intestinal tuberculosis and 5 of 44 patients with Crohn’s disease tested positive by TB PCR. The sensitivity, specificity, positive predictive and negative predictive values for TB PCR in distinguishing tuberculosis from Crohn’s disease were 0.79 (95% confidence interval 0.57–0.92), 0.88 (0.75–0.96), 0.79 (0.57–0.92) and 0.88 (0.75–0.96), respectively. A combination of fecal TB PCR with mycobacterial culture of mucosal biopsy specimens identified 23 of 24 (96.2%) of patients with intestinal TB, with sensitivity, specificity, positive predictive and negative predictive values (95% CI) of 0.95 (0.78–0.99), 0.88 (0.75–0.96), 0.82 (0.63–0.93) and 0.97 (0.86–0.99), respectively.

Conclusion

Fecal TB PCR is a good screening test to distinguish intestinal tuberculosis from Crohn’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Desai HG, Gupte PA. Increasing incidence of Crohn’s disease in India: is it related to improved sanitation? Indian J Gastroenterol. 2005;24:23–4.

    CAS  PubMed  Google Scholar 

  2. Das K, Ghoshal UC, Dhali GK, Benjamin J, Ahuja V, Makharia GK. Crohn’s disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci. 2009;54:1099–107.

    Article  PubMed  Google Scholar 

  3. Isbister WH, Hubler M. Inflammatory bowel disease in Saudi Arabia: presentation and initial management. J Gastroenterol Hepatol. 1998;13:1119–24.

    Article  CAS  PubMed  Google Scholar 

  4. Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol. 2005;21:408–13.

    PubMed  Google Scholar 

  5. Dye C. Global epidemiology of tuberculosis. Lancet. 2006;367:938–40.

    Article  PubMed  Google Scholar 

  6. Almadi MA, Ghosh S, Aljebreen AM. Differentiating intestinal tuberculosis from Crohn’s disease: a diagnostic challenge. Am J Gastroenterol. 2009;104:1003–12.

    Article  PubMed  Google Scholar 

  7. Epstein D, Watermeyer G, Kirsch R. Review article: the diagnosis and management of Crohn’s disease in populations with high-risk rates for tuberculosis. Aliment Pharmacol Ther. 2007;25:1373–88.

    Article  CAS  PubMed  Google Scholar 

  8. Amarapurkar DN, Patel ND, Rane PS. Diagnosis of Crohn’s disease in India where tuberculosis is widely prevalent. World J Gastroenterol. 2008;14:741–6.

    Article  PubMed  Google Scholar 

  9. Pulimood AB, Peter S, Ramakrishna B, et al. Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn’s disease. J Gastroenterol Hepatol. 2005;20:688–96.

    Article  PubMed  Google Scholar 

  10. Makharia GK, Sachdev V, Gupta R, Lal S, Pandey RM. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn’s disease and intestinal tuberculosis. Dig Dis Sci. 2007;52:33–9.

    Article  PubMed  Google Scholar 

  11. Amarapurkar DN, Patel ND, Amarapurkar AD, Agal S, Baigal R, Gupte P. Tissue polymerase chain reaction in diagnosis of intestinal tuberculosis and Crohn’s disease. J Assoc Physicians India. 2004;52:863–7.

    CAS  PubMed  Google Scholar 

  12. Kim KM, Lee A, Choi KY, Lee KY, Kwak JJ. Intestinal tuberculosis: clinicopathologic analysis and diagnosis by endoscopic biopsy. Am J Gastroenterol. 1998;93:606–9.

    Article  CAS  PubMed  Google Scholar 

  13. Gan HT, Chen YQ, Ouyang Q, Bu H, Yang XY. Differentiation between intestinal tuberculosis and Crohn’s disease in endoscopic biopsy specimens by polymerase chain reaction. Am J Gastroenterol. 2002;97:1446–51.

    Article  PubMed  Google Scholar 

  14. Makharia GK, Srivastava S, Das P, et al. Clinical, endoscopic, and histological differentiations between Crohn’s disease and intestinal tuberculosis. Am J Gastroenterol. 2010;105:642–51.

    Article  PubMed  Google Scholar 

  15. Pulimood AB, Peter S, Rook GW, Donoghue HD. In situ PCR for Mycobacterium tuberculosis in endoscopic mucosal biopsy specimens of intestinal tuberculosis and Crohn disease. Am J Clin Pathol. 2008;129:846–51.

    Article  CAS  PubMed  Google Scholar 

  16. Balamurugan R, Venkataraman S, John KR, Ramakrishna BS. PCR amplification of the IS6110 insertion element of Mycobacterium tuberculosis in fecal samples from patients with intestinal tuberculosis. J Clin Microbiol. 2006;44:1884–6.

    Article  CAS  PubMed  Google Scholar 

  17. Shah S, Thomas V, Mathan M, et al. Colonoscopic study of 50 patients with colonic tuberculosis. Gut. 1992;33:347–51.

    Article  CAS  PubMed  Google Scholar 

  18. Pugazhendhi S, Amte A, Balamurugan R, Subramanian V, Ramakrishna BS. Common NOD2 mutations are absent in patients with Crohn’s disease in India. Indian J Gastroenterol. 2008;27:201–3.

    PubMed  Google Scholar 

  19. Hogan WJ, Hensley GT, Geenen JE. Endoscopic evaluation of inflammatory bowel disease. Med Clin North Am. 1980;64:1083–102.

    CAS  PubMed  Google Scholar 

  20. Katoch VM. Newer diagnostic techniques for tuberculosis. Indian J Med Res. 2004;120:418–28.

    CAS  PubMed  Google Scholar 

  21. Chauhan DS, Sharma VD, Parashar D, et al. Molecular typing of Mycobacterium tuberculosis isolates from different parts of India based on IS6110 element polymorphism using RFLP analysis. Indian J Med Res. 2007;125:577–81.

    CAS  PubMed  Google Scholar 

  22. Singh SK, Verma R, Shah DH. Molecular fingerprinting of clinical isolates of Mycobacterium bovis and Mycobacterium tuberculosis from India by restriction fragment length polymorphism (RFLP). J Vet Sci. 2004;5:331–5.

    PubMed  Google Scholar 

  23. Tzen CY, Wu TY, Tzen CY. Detection of mycobacteria in Crohn’s disease by a broad spectrum polymerase chain reaction. J Formos Med Assoc. 2006;105:290–8.

    Article  CAS  PubMed  Google Scholar 

  24. Chiappini E, de Martino M, Mangiantini F, Lionetti P. Crohn disease and mycobacterial infection in children: an intriguing relationship. J Pediatr Gastroenterol Nutr. 2009;49:550–8.

    Article  PubMed  Google Scholar 

  25. Garcia-Vidal C, Rodríguez-Fernández S, Teijón S, et al. Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention. Eur J Clin Microbiol Infect Dis. 2009;28:331–7.

    Article  CAS  PubMed  Google Scholar 

  26. Bruns H, Meinken C, Schauenberg P, et al. Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J Clin Invest. 2009;119:1167–77.

    Article  CAS  PubMed  Google Scholar 

  27. Caviglia R, Boskoski I, Cicala M. Long-term treatment with infliximab in inflammatory bowel disease: safety and tolerability issues. Expert Opin Drug Saf. 2008;7:617–32.

    Article  CAS  PubMed  Google Scholar 

  28. Mow WS, Abreu-Martin MT, Papadakis KA, Pitchon HE, Targan SR, Vasiliauskas EA. High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy. Clin Gastroenterol Hepatol. 2004;2:309–13.

    Article  PubMed  Google Scholar 

  29. Lalvani A, Millington KA. Screening for tuberculosis infection prior to initiation of anti-TNF therapy. Autoimmun Rev. 2008;8:147–52.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The study was supported by an intramural Fluid Research Grant from the Christian Medical College, Vellore. Balamurugan Ramadass was supported by a Senior Research Fellowship from the Indian Council of Medical Research. The laboratory was supported by FIST grant no. SR/FST/LSI-141/2002 from the Department of Science and Technology, Government of India.

Competing Interest

None to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Balakrishnan S. Ramakrishna.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramadass, B., Chittaranjan, S., Subramanian, V. et al. Fecal polymerase chain reaction for Mycobacterium tuberculosis IS6110 to distinguish Crohn’s disease from intestinal tuberculosis. Indian J Gastroenterol 29, 152–156 (2010). https://doi.org/10.1007/s12664-010-0022-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-010-0022-3

Keywords

Navigation